跳至主要内容
临床试验/NCT04677699
NCT04677699Enrolling By Invitation不适用

Combined Antibody Screening for Celiac and Diabetes Evaluation

Pacific Northwest Research Institute1 个研究点 分布在 1 个国家目标入组 64,410 人开始时间: 2020年12月最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
64,410
试验地点
1
主要终点
Diagnosis of Type 1 Diabetes

研究概览

简要总结

The CASCADE Study (Combined Antibody Screening for Celiac and Diabetes Evaluation) is an observational study whose primary goal is to show that population-based screening for advanced prediction of type 1 diabetes (T1D) and celiac disease (CD) is feasible to prevent diabetic ketoacidosis (DKA), improve celiac disease diagnosis, and ultimately gain public health acceptance to facilitate future prevention. It has two arms, a Birth Cohort and a Kids (cross sectional) Cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Child must be between 0 to 8 months in age or between 4 to 7 years in age. Child must be born in the state of Washington.

排除标准

  • 未提供

结局指标

主要结局

Diagnosis of Type 1 Diabetes

时间窗: 5 years

Diagnosis of Celiac Disease

时间窗: 5 years

次要结局

  • Severity of disease at diagnosis(5 years)

研究者

发起方
Pacific Northwest Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

William Hagopian

Director of Diabetes Program

Pacific Northwest Research Institute

研究点 (1)

Loading locations...

相似试验